open access
Pleuropericardial compromise associated with Graves’ disease — a diagnostic challenge
, 2, 2, 2, 3
Affiliations- Division of Endocrinology, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
- Sociedad Científica de San Fernando, Lima, Peru
- Division of Endocrinology, Clínica Stella Maris, Lima, Peru
open access
Abstract
Not required for Clinical Vignette.
Abstract
Not required for Clinical Vignette.
Keywords
Graves’ disease; pleurisy; pericarditis; antithyroid agents
About this articleTitle
Pleuropericardial compromise associated with Graves’ disease — a diagnostic challenge
Journal
Issue
Article type
Clinical vignette
Pages
381-382
Published online
2022-03-25
Page views
4698
Article views/downloads
476
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2022;73(2):381-382.
Keywords
Graves’ disease
pleurisy
pericarditis
antithyroid agents
Authors
José Luis Paz-Ibarra
Diego Enrique Sueldo-Espinoza
Ronald Vicente Concha-Tamo
Vladimir Zamamé-Ramírez
Marcio José Concepción-Zavaleta
References (5)- Fanlo P, Tiberio G. [Extrapulmonary tuberculosis]. An Sist Sanit Navar. 2007; 30 Suppl 2: 143–162.
- Leo SDe, Lee S, Braverman L. Hyperthyroidism. Lancet. 2016; 388(10047): 906–918.
- Gondal M, Hussain A, Yousuf H, et al. Double trouble - thyro-pericarditis: rare presentation of Graves' disease as pericarditis-a case report. Eur Heart J Case Rep. 2020; 4(6): 1–5.
- Gupta P, Chhabra L, Hiendlmayr B, et al. Thyrotoxic pericarditis: An underappreciated phenomenon. Int J Cardiol. 2015; 198: 32–33.
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016; 26(10): 1343–1421.
